Please login to the form below
Halesway changes name to FCB Halesway
Move aligns agency more closely with its parent company FCB Health
UK healthcare communications company Halesway has changed its name as part of plans to align the agency with its award-winning parent company FCB Health.
Now known as FCB Halesway, the rebrand is intended to raise the agency's global profile and make prospective clients aware of its close relationship with the healthcare practice arm of FCB, part of the Interpublic Group.
Acquired in 2014, Halesway was the advertising network's first international addition, with the UK firm strengthening FCB's European presence and gaining access to the company's strategic, creative and digital resources.
It took place after the New York-based parent company underwent its own rebrand, changing from US-focused Draftfcb to become a pan-European and global communications network.
Share
Related Hub content
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
-
Digital Account Director
-
Salary TBC
-
Project Manager/ Account Manager
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Novartis first to benefit from NICE advice on ‘patient preference’
- GW Pharma's cannabis-based medicine to be tested in dementia
- Immuno-oncology in 2019: the rapid evolution continues
- Novartis’ Egatan gains US approval for neglected tropical disease
- Keytruda combo outshines Opdivo in kidney cancer
- Forster Communications and Cello Health launch sustainability service
- Excellent teamwork and interdepartmental collaboration lead to double promotion at Porterhouse Medical
- New ‘NHSX’ unit will lead health service digital transformation
- Gyroscope's gene therapy given to first dry AMD patient
- Roche’s rival to Bayer’s Vitrakvi gets speedy FDA review
- ‘Inflexible’ NICE blocking access to rare disease drugs
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- 2019: CRISPR and therapeutic gene editing comes of age
- Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
- The 10-year Web Challenge
- Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
- Downloadable Pack: Understanding Multiple Sclerosis
- Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Quick links
Infographics
